pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4491 |
Genomic Coordinates | chr11: 111347757 - 111347824 |
Description | Homo sapiens miR-4491 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4491 | ||||||||||||||||||||||||
Sequence | 46| AAUGUGGACUGGUGUGACCAAA |67 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | POTED | ||||||||||
Synonyms | A26B3, ANKRD21, CT104.1, POTE, POTE-21, POTE21 | ||||||||||
Description | POTE ankyrin domain family member D | ||||||||||
Transcript | NM_174981 | ||||||||||
Expression | |||||||||||
Putative miRNA Targets on POTED | |||||||||||
3'UTR of POTED (miRNA target sites are highlighted) |
>POTED|NM_174981|3'UTR
1 GTACAGTGGACAGCTTAGG
Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||
DRVs in gene 3'UTRs | |||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 317754.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 317754.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 317754.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000299443.5 | 3UTR | CAUUCCUAUUUCUCCACAUCCUCUCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000299443.5 | 3UTR | CAUUCCUAUUUCUCCACAUCCUCUCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000299443.5 | 3UTR | CAUUCCUAUUUCUCCACAUCCUCUCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1065669 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000299443.5 | 3UTR | UUCCUAUUUCUCCACAUCCUCUCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000299443.5 | 3UTR | CAUUCCUAUUUCUCCACAUCCUCUCCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000299443.5 | 3UTR | UUCCUAUUUCUCCACAUCCUCUCCAGCAUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
67 hsa-miR-4491 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT056779 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT061577 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT063828 | SRP9 | signal recognition particle 9 | 2 | 4 | ||||||||
MIRT102306 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | 2 | 10 | ||||||||
MIRT186634 | COX20 | COX20, cytochrome c oxidase assembly factor | 2 | 8 | ||||||||
MIRT191243 | STYX | serine/threonine/tyrosine interacting protein | 2 | 2 | ||||||||
MIRT195908 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 4 | ||||||||
MIRT240343 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT271178 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT286219 | TMEM97 | transmembrane protein 97 | 2 | 4 | ||||||||
MIRT314182 | OCLN | occludin | 2 | 4 | ||||||||
MIRT323938 | AKAP2 | A-kinase anchoring protein 2 | 2 | 4 | ||||||||
MIRT323940 | PALM2-AKAP2 | PALM2-AKAP2 readthrough | 2 | 4 | ||||||||
MIRT340113 | TXLNA | taxilin alpha | 2 | 2 | ||||||||
MIRT450333 | LRWD1 | leucine rich repeats and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT451283 | ZNF101 | zinc finger protein 101 | 2 | 2 | ||||||||
MIRT451879 | SOD2 | superoxide dismutase 2 | 2 | 8 | ||||||||
MIRT453577 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT454366 | ASAH2 | N-acylsphingosine amidohydrolase 2 | 2 | 2 | ||||||||
MIRT454797 | STOML3 | stomatin like 3 | 2 | 2 | ||||||||
MIRT459801 | POTED | POTE ankyrin domain family member D | 2 | 10 | ||||||||
MIRT460911 | POLQ | DNA polymerase theta | 2 | 2 | ||||||||
MIRT468082 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 6 | ||||||||
MIRT470281 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | 2 | 2 | ||||||||
MIRT471876 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT476147 | GPR137C | G protein-coupled receptor 137C | 2 | 8 | ||||||||
MIRT478056 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 10 | ||||||||
MIRT501054 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 4 | ||||||||
MIRT501732 | OVOL1 | ovo like transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT502214 | HSPB8 | heat shock protein family B (small) member 8 | 2 | 2 | ||||||||
MIRT505243 | UBE2D3 | ubiquitin conjugating enzyme E2 D3 | 2 | 2 | ||||||||
MIRT505957 | RAN | RAN, member RAS oncogene family | 2 | 6 | ||||||||
MIRT507996 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT510433 | ZNF207 | zinc finger protein 207 | 2 | 6 | ||||||||
MIRT510827 | SBNO1 | strawberry notch homolog 1 | 2 | 4 | ||||||||
MIRT511493 | HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 2 | 4 | ||||||||
MIRT512129 | CREBL2 | cAMP responsive element binding protein like 2 | 2 | 8 | ||||||||
MIRT514512 | SHISA9 | shisa family member 9 | 2 | 4 | ||||||||
MIRT516482 | RAB32 | RAB32, member RAS oncogene family | 2 | 4 | ||||||||
MIRT519514 | RBM22 | RNA binding motif protein 22 | 2 | 4 | ||||||||
MIRT523367 | GTF2A1 | general transcription factor IIA subunit 1 | 2 | 2 | ||||||||
MIRT524217 | DDI2 | DNA damage inducible 1 homolog 2 | 2 | 6 | ||||||||
MIRT524649 | C4orf32 | family with sequence similarity 241 member A | 2 | 2 | ||||||||
MIRT528297 | ZNF76 | zinc finger protein 76 | 2 | 2 | ||||||||
MIRT528577 | ITGB3BP | integrin subunit beta 3 binding protein | 2 | 2 | ||||||||
MIRT530458 | SULT1B1 | sulfotransferase family 1B member 1 | 2 | 2 | ||||||||
MIRT535774 | MYCN | MYCN proto-oncogene, bHLH transcription factor | 2 | 2 | ||||||||
MIRT544239 | CCBL2 | kynurenine aminotransferase 3 | 2 | 2 | ||||||||
MIRT546733 | RNF217 | ring finger protein 217 | 2 | 2 | ||||||||
MIRT550360 | INCENP | inner centromere protein | 2 | 4 | ||||||||
MIRT553343 | TRPC3 | transient receptor potential cation channel subfamily C member 3 | 2 | 4 | ||||||||
MIRT556629 | LAPTM4A | lysosomal protein transmembrane 4 alpha | 2 | 2 | ||||||||
MIRT558006 | FAM122B | family with sequence similarity 122B | 2 | 2 | ||||||||
MIRT558994 | CA8 | carbonic anhydrase 8 | 2 | 2 | ||||||||
MIRT560418 | ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 2 | 2 | ||||||||
MIRT565717 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT566271 | PTAR1 | protein prenyltransferase alpha subunit repeat containing 1 | 2 | 2 | ||||||||
MIRT568161 | CCDC6 | coiled-coil domain containing 6 | 2 | 2 | ||||||||
MIRT569753 | C2orf71 | chromosome 2 open reading frame 71 | 2 | 2 | ||||||||
MIRT573959 | FIGNL1 | fidgetin like 1 | 2 | 2 | ||||||||
MIRT574530 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT609453 | CCDC149 | coiled-coil domain containing 149 | 2 | 2 | ||||||||
MIRT614047 | THBS2 | thrombospondin 2 | 2 | 2 | ||||||||
MIRT628418 | ATMIN | ATM interactor | 2 | 2 | ||||||||
MIRT689556 | XPO6 | exportin 6 | 2 | 2 | ||||||||
MIRT725598 | CDH7 | cadherin 7 | 2 | 2 | ||||||||
MIRT735561 | TRIM7 | tripartite motif containing 7 | 3 | 0 |